Cargando…
Antimyeloma Effects of the Heat Shock Protein 70 Molecular Chaperone Inhibitor MAL3-101
Multiple myeloma (MM) is the second most common hematologic malignancy and remains incurable, primarily due to the treatment-refractory/resistant nature of the disease. A rational approach to this compelling challenge is to develop new drugs that act synergistically with existing effective agents. T...
Autores principales: | Braunstein, Marc J., Scott, Sadeaqua S., Scott, Craig M., Behrman, Shannon, Walter, Peter, Wipf, Peter, Coplan, Jeremy D., Chrico, William, Joseph, Danielle, Brodsky, Jeffrey L., Batuman, Olcay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3184436/ https://www.ncbi.nlm.nih.gov/pubmed/21977030 http://dx.doi.org/10.1155/2011/232037 |
Ejemplares similares
-
The HSP70 Modulator MAL3-101 Inhibits Merkel Cell Carcinoma
por: Adam, Christian, et al.
Publicado: (2014) -
Bisphosphonates as antimyeloma drugs
por: Modi, N D, et al.
Publicado: (2012) -
Understanding the Role of T-Cells in the Antimyeloma Effect of Immunomodulatory Drugs
por: D'Souza, Criselle, et al.
Publicado: (2021) -
Heat shock-induced chaperoning by Hsp70 is enabled in-cell
por: Guin, Drishti, et al.
Publicado: (2019) -
Homoharringtonine Exerts an Antimyeloma Effect by Promoting Excess Parkin-Dependent Mitophagy
por: Zhang, Yanyu, et al.
Publicado: (2020)